Perjeta 420mg Injection

Perjeta 420mg Injection is an anticancer drug that contains Pertuzumab as its active ingredient. It is utilized for the treatment of a specific type of breast cancer known as HER2-positive breast cancer, in conjunction with other chemotherapy agents. Cancer is characterized by the uncontrolled and abnormal proliferation of cells.

This injection is not advised for use in adolescents and children under the age of 18. Prior to using this medication, it is crucial to inform your healthcare provider if you have a history of heart issues or have undergone chemotherapy. It is important to employ effective birth control methods during the treatment and for at least six months following the final dose.

Before commencing treatment with this Pertuzumab injection, notify your doctor if you have any kidney conditions. Patients with kidney disease should use this medication with caution. Ensure that you disclose all medications you are currently taking, including supplements and herbal products, to your physician before starting this treatment. Do not discontinue this medication without consulting your doctor first.